Related Experiment Video
Updated: Jul 5, 2026

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice
Published on: December 27, 2024
Malignant spinal meningioma in a CD-1 mouse
Emmanuelle Balme1, Daniel Robert Roth, Elias Perentes
1Department of pathology, Veterinary School of Alfort, 94704 Maisons-Alfort, France.
Spontaneous malignant spinal meningiomas are rare in mice. This case report details a malignant meningioma in a CD-1 mouse, highlighting its spinal cord invasion and unique immunohistochemical profile.
Area of Science:
- Veterinary Pathology
- Oncology
- Neuroscience
Background:
- Spontaneous meningiomas are uncommon in laboratory animals, with exceptions in specific rat strains and B6C3F1 mice.
- Meningiomas are tumors arising from the meninges, the membranes surrounding the brain and spinal cord.
Observation:
- A male CD-1 mouse presented with severe apathy and hindleg paresis.
- Necropsy revealed no macroscopic lesions, but microscopic examination identified a 3mm malignant meningioma in the distal spinal cord.
Findings:
- The tumor invaded the vertebral canal, nerve roots, and dorsal root ganglia.
- Histopathology showed a highly cellular neoplasm with epithelioid and sarcomatous areas, moderate mitotic activity, and vimentin immunoreactivity.
- Immunohistochemistry was negative for PAS, reticulin, chromogranin A, GFAP, cytokeratin, and S-100 protein.
Implications:
- This case expands the understanding of spontaneous meningioma occurrence in CD-1 mice.
- The findings contribute to the differential diagnosis of spinal cord tumors in laboratory rodents.
- Detailed histopathological and immunohistochemical characterization is crucial for accurate diagnosis of rare neoplasms.
More Related Videos
07:17A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
Published on: January 29, 2021
06:25Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
Published on: March 29, 2024